Allianz Asset Management
ESPR

Allianz Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Allianz Asset Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,205
Closed -$183K – 2586
2021
Q3 		$183K Sell
15,205
-4,500
-23% -$65.5K ﹤0.01% 2504
2021
Q2 		$417K Sell
19,705
-14,640
-43% -$353K ﹤0.01% 2127
2021
Q1 		$963K Hold
34,345
– – ﹤0.01% 1657
2020
Q4 		$893K Sell
34,345
-25,080
-42% -$751K ﹤0.01% 1511
2020
Q3 		$2.21M Sell
59,425
-1,326
-2% -$52.5K ﹤0.01% 1231
2020
Q2 		$3.12M Buy
60,751
+15,347
+34% +$642K ﹤0.01% 1418
2020
Q1 		$1.43M Buy
45,404
+5,482
+14% +$289K ﹤0.01% 1647
2019
Q4 		$2.38M Buy
+39,922
New +$1.79M ﹤0.01% 1790
2019
Q2 		– Sell
-31,078
Closed -$1.25M – 2701
2019
Q1 		$1.25M Sell
31,078
-12,389
-29% -$556K ﹤0.01% 2020
2018
Q4 		$1.97M Sell
43,467
-23,638
-35% -$1.14M ﹤0.01% 1772
2018
Q3 		$2.98M Hold
67,105
– – ﹤0.01% 1794
2018
Q2 		$2.63M Buy
67,105
+44,654
+199% +$2.26M ﹤0.01% 1822
2018
Q1 		$1.62M Buy
+22,451
New +$1.65M ﹤0.01% 2020
2015
Q4 		– Sell
-102,020
Closed -$2.41M – 2463
2015
Q3 		$2.41M Buy
102,020
+36,480
+56% +$2.29M ﹤0.01% 1532
2015
Q2 		$5.36M Buy
65,540
+373
+0.6% +$36.5K 0.01% 1358
2015
Q1 		$6.03M Buy
65,167
+30,600
+89% +$1.97M 0.01% 1148
2014
Q4 		$1.4M Buy
+34,567
New +$1.06M ﹤0.01% 1701

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Allianz Asset Management's ESPR Position: Q4 2021 in Review

Allianz Asset Management sold out of Esperion Therapeutics (ESPR) in Q4 2021, closing a stake of 15,205 shares — an estimated $183K sold.

Allianz Asset Management first reported a position in ESPR in Q4 2014 and held it in 17 quarters. The position peaked at $6.03M in Q1 2015. 133 funds tracked by Wall St. Rank hold ESPR as of Q4 2021.

  • Allianz Asset Management reported no remaining Esperion Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Allianz Asset Management sold 15,205 Esperion Therapeutics shares in Q4 2021, an estimated $183K.
  • Allianz Asset Management first reported a position in Esperion Therapeutics in Q4 2014 and held it in 17 quarters.
  • Allianz Asset Management's Esperion Therapeutics position peaked at $6.03M in Q1 2015.
  • 133 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2021.

Based on Allianz Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.